Parenchymal hematoma and total lesion volume in combined IV/IA revascularization stroke therapy

Journal of NeuroInterventional Surgery

Volumn 4, Issue 4, 2012, Pages 256-260

  Tao, Haiyang ^a   Ramadas, Gowri ^a   Carrozzella, Janice ^a   Khatri, Pooja ^a   Broderick, Joseph ^a   Spilker, Judith ^a   Tomsick, Thomas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ARTICLE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE ASSOCIATION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INTERMETHOD COMPARISON; MEASUREMENT ERROR; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; OUTCOME ASSESSMENT; PARENCHYMAL HEMATOMA VOLUME; PRIORITY JOURNAL; SYNDROME DELINEATION; TOTAL LESION VOLUME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL REVASCULARIZATION; COMBINED MODALITY THERAPY; HEMATOMA, EPIDURAL, CRANIAL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MIDDLE AGED; STROKE; TISSUE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 84862994047     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2011-010062     Document Type: Article

References (12)

1. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330-4.
2. Hom J, Dankbaar JW, Schneider T, et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR 2011;32:41-8.
3. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in prediciting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Program Early CT Score. Lancet 2000;355:1670-4. (Pubitemid 30248478)
4. Fiorelli M, Bastianello S, Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct, relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) Cohort. Stroke 1999;30:2280-4. (Pubitemid 29517722)
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
6. Khatri P, Neff J, Broderick J, et al. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-3. (Pubitemid 41566966)
7. Christoforidis GA, Slivka A, Mohammed Y, et al. Size matters. Hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis. Stroke 2007;38:1799-804. (Pubitemid 46847250)
8. Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage: a powerful predictor of 30-day mortality. Stroke 1993;24:987-93. (Pubitemid 23201455)
9. Gebel GM, Sila CA, Sloan MA, et al. Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. Stroke 1998;29:1799-801. (Pubitemid 28399966)
10. Khatri P, Broderick JP, Khoury JC, et al. Microcatheter contrast injections during intraarterial thrombolysis increases intracranial hemorrhage risk. Stroke 2008;39:3283-7.
11. Khatri R, Khatri P, Khoury J, et al. Microcatheter contrast injections during intraarterial thrombolysis increase parenchymal hematoma risk: registry experience. Stroke 2007;38:454.
12. Kurosawa Y, Lu A, Khatri P, et al. Administration in a rat middle cerebral artery occlusion and reperfusion model: possible effects on intracerebral hemorrhage. Stroke 2010;41:1013-17.